Hepatocellular Carcinoma and Gastroenteropancreatic Neuroendocrine Tumors: Potential Role of Other Positron Emission Tomography Radiotracers

Seminars in Nuclear Medicine, 06/08/2012

Jadvar H – This article reviews the role of fluorodeoxyglucose (FDG) and non–FDG radiotracers in the imaging evaluation of patients with gastroenteropancreatic neuroendocrine tumors or hepatocellular carcinoma.

Print Article Summary Cat 2 CME Report